Fidelity Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Fidelity Investments’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,146,049	Closed	-$123M	–	5654
2023 Q1	$123M	Buy	1,146,049 +391,329	+52%	+$45M	0.01%	916
2022 Q4	$83M	Buy	754,720 +337,481	+81%	+$21.9M	0.01%	1043
2022 Q3	$24.6M	Buy	417,239 +64,054	+18%	+$2.93M	﹤0.01%	1546
2022 Q2	$9.97M	Buy	353,185 +51,488	+17%	+$1.49M	﹤0.01%	1969
2022 Q1	$11.4M	Buy	301,697 +497	+0.2%	+$19.6K	﹤0.01%	2058
2021 Q4	$11.9M	Hold	301,200	–	–	﹤0.01%	2043
2021 Q3	$7.14M	Sell	301,200 -111,600	-27%	-$2.63M	﹤0.01%	2253
2021 Q2	$10.1M	Sell	412,800 -143,400	-26%	-$3.2M	﹤0.01%	2101
2021 Q1	$10.2M	Buy	+556,200	New	+$11.5M	﹤0.01%	2030

Other funds holding RXDX

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Fidelity Investments's RXDX Position: Q2 2023 in Review

Fidelity Investments sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 1,146,049 shares — an estimated $123M sold.

Fidelity Investments first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $123M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Fidelity Investments reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Fidelity Investments sold 1,146,049 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $123M.
Fidelity Investments first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Fidelity Investments's Prometheus Biosciences, Inc. Common Stock position peaked at $123M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.